Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet
Table 1
Demographic, anthropometric, and clinical characteristics at baseline of the study participants, according to treatment with melatonin (MEL group) or placebo (PL group).
Parameter
MEL group
PL group
value
n (male/female)
15 (5/10)
15 (5/10)
Age (yrs)
37.7 ± 3.40
36.3 ± 4.18
0.79
Body weight (kg)
113.6 ± 4.74
114.4 ± 7.31
0.93
Height (m)
1.74 ± 0.024
1.72 ± 0.025
0.74
BMI (kg/m2)
37.8 ± 1.51
38.2 ± 1.94
0.85
Waist circumference (cm)
112.4 ± 3.50
112.6 ± 4.13
0.97
Hip circumference (cm)
121.5 ± 2.78
123.4 ± 4.42
0.71
Waist-hip ratio
0.93 ± 0.04
0.92 ± 0.04
0.82
SBP
124.2 ± 2.32
125.0 ± 4.36
0.87
DBP
75.8 ± 1.73
76.7 ± 2.35
0.78
Total cholesterol (mg/dL)
196.7 ± 5.99
196.6 ± 7.02
0.99
Glucose (mg/dL)
94.0 ± 1.90
99.9 ± 4.70
0.15
Each value is mean ± S.E.M. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure.
